Trials / Unknown
UnknownNCT04031989
Repository of Phase Signals for Pulmonary Hypertension Algorithm Development
Phase Signal Acquisition System (PSAQ): Repository of Phase Signals for Pulmonary Hypertension Algorithm Development
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,500 (estimated)
- Sponsor
- Analytics For Life · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to Right Heart Cath (RHC). The repository data will be used for the purposes of research, development, optimization and testing of machine-learning algorithms developed by CorVista Health (formerly Analytics 4 Life).
Detailed description
Male and Female subjects will be uniquely and consecutively enrolled into one group to support populating a repository of phase signals. Resting phase signals will be collected in all patients who meet inclusion/exclusion criteria and have signed an informed consent form. This study consists of a screening visit, resting phase signal collection (study procedure), and right heart catheterization. In this study, resting phase signals will be acquired in subjects prior to Right Heart Catheterization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CorVista Capture | The CorVista System is a medical device system that is being developed to collect phase signals from patients to support the development and testing of machine learned algorithms developed by CorVista Health. Data collected with the CorVista System during this study will not be used to guide treatment. |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2024-05-15
- Completion
- 2024-08-31
- First posted
- 2019-07-25
- Last updated
- 2024-03-04
Locations
17 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04031989. Inclusion in this directory is not an endorsement.